Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
The latest research study released by Market IntelliX evaluates market size and forecasts of Human Milk Oligosaccharides (HMO) in global, including the following market information:
Global Human Milk Oligosaccharides (HMO) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Milk Oligosaccharides (HMO) Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Human Milk Oligosaccharides (HMO) companies in 2021 (%)
The global Human Milk Oligosaccharides (HMO) market was valued at 396 million in 2021 and is projected to reach US$ 1015.7 million by 2028, at a CAGR of 14.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
2'-FL & 3-FL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), ZuChem and Glycom, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Human Milk Oligosaccharides (HMO) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Human Milk Oligosaccharides (HMO) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, by Type, 2021 (%)
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Global Human Milk Oligosaccharides (HMO) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, by Application, 2021 (%)
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
Global Human Milk Oligosaccharides (HMO) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Milk Oligosaccharides (HMO) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Milk Oligosaccharides (HMO) revenues share in global market, 2021 (%)
Key companies Human Milk Oligosaccharides (HMO) sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Human Milk Oligosaccharides (HMO) sales share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Human Milk Oligosaccharides (HMO) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Milk Oligosaccharides (HMO) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Milk Oligosaccharides (HMO) Overall Market Size
2.1 Global Human Milk Oligosaccharides (HMO) Market Size: 2021 VS 2028
2.2 Global Human Milk Oligosaccharides (HMO) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Milk Oligosaccharides (HMO) Sales: 2017-2028
3 Company Landscape
3.1 Top Human Milk Oligosaccharides (HMO) Players in Global Market
3.2 Top Global Human Milk Oligosaccharides (HMO) Companies Ranked by Revenue
3.3 Global Human Milk Oligosaccharides (HMO) Revenue by Companies
3.4 Global Human Milk Oligosaccharides (HMO) Sales by Companies
3.5 Global Human Milk Oligosaccharides (HMO) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Milk Oligosaccharides (HMO) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Milk Oligosaccharides (HMO) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Milk Oligosaccharides (HMO) Players in Global Market
3.8.1 List of Global Tier 1 Human Milk Oligosaccharides (HMO) Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Milk Oligosaccharides (HMO) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Milk Oligosaccharides (HMO) Market Size Markets, 2021 & 2028
4.1.2 2'-FL & 3-FL
4.1.3 Sialyllactose
4.1.4 LNT & LNnT
4.2 By Type - Global Human Milk Oligosaccharides (HMO) Revenue & Forecasts
4.2.1 By Type - Global Human Milk Oligosaccharides (HMO) Revenue, 2017-2022
4.2.2 By Type - Global Human Milk Oligosaccharides (HMO) Revenue, 2023-2028
4.2.3 By Type - Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
4.3 By Type - Global Human Milk Oligosaccharides (HMO) Sales & Forecasts
4.3.1 By Type - Global Human Milk Oligosaccharides (HMO) Sales, 2017-2022
4.3.2 By Type - Global Human Milk Oligosaccharides (HMO) Sales, 2023-2028
4.3.3 By Type - Global Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
4.4 By Type - Global Human Milk Oligosaccharides (HMO) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Human Milk Oligosaccharides (HMO) Market Size, 2021 & 2028
5.1.2 Infant Formula
5.1.3 Functional Food & Beverages
5.1.4 Food/Medical Supplements
5.1.5 Others
5.2 By Application - Global Human Milk Oligosaccharides (HMO) Revenue & Forecasts
5.2.1 By Application - Global Human Milk Oligosaccharides (HMO) Revenue, 2017-2022
5.2.2 By Application - Global Human Milk Oligosaccharides (HMO) Revenue, 2023-2028
5.2.3 By Application - Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
5.3 By Application - Global Human Milk Oligosaccharides (HMO) Sales & Forecasts
5.3.1 By Application - Global Human Milk Oligosaccharides (HMO) Sales, 2017-2022
5.3.2 By Application - Global Human Milk Oligosaccharides (HMO) Sales, 2023-2028
5.3.3 By Application - Global Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
5.4 By Application - Global Human Milk Oligosaccharides (HMO) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Human Milk Oligosaccharides (HMO) Market Size, 2021 & 2028
6.2 By Region - Global Human Milk Oligosaccharides (HMO) Revenue & Forecasts
6.2.1 By Region - Global Human Milk Oligosaccharides (HMO) Revenue, 2017-2022
6.2.2 By Region - Global Human Milk Oligosaccharides (HMO) Revenue, 2023-2028
6.2.3 By Region - Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
6.3 By Region - Global Human Milk Oligosaccharides (HMO) Sales & Forecasts
6.3.1 By Region - Global Human Milk Oligosaccharides (HMO) Sales, 2017-2022
6.3.2 By Region - Global Human Milk Oligosaccharides (HMO) Sales, 2023-2028
6.3.3 By Region - Global Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Milk Oligosaccharides (HMO) Revenue, 2017-2028
6.4.2 By Country - North America Human Milk Oligosaccharides (HMO) Sales, 2017-2028
6.4.3 US Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.4.4 Canada Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.4.5 Mexico Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Milk Oligosaccharides (HMO) Revenue, 2017-2028
6.5.2 By Country - Europe Human Milk Oligosaccharides (HMO) Sales, 2017-2028
6.5.3 Germany Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5.4 France Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5.5 U.K. Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5.6 Italy Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5.7 Russia Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5.8 Nordic Countries Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.5.9 Benelux Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Milk Oligosaccharides (HMO) Revenue, 2017-2028
6.6.2 By Region - Asia Human Milk Oligosaccharides (HMO) Sales, 2017-2028
6.6.3 China Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.6.4 Japan Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.6.5 South Korea Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.6.6 Southeast Asia Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.6.7 India Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Milk Oligosaccharides (HMO) Revenue, 2017-2028
6.7.2 By Country - South America Human Milk Oligosaccharides (HMO) Sales, 2017-2028
6.7.3 Brazil Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.7.4 Argentina Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Sales, 2017-2028
6.8.3 Turkey Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.8.4 Israel Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.8.5 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
6.8.6 UAE Human Milk Oligosaccharides (HMO) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Human Milk Oligosaccharides (HMO) Major Product Offerings
7.1.4 Abbott Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Key News
7.2 Inbiose
7.2.1 Inbiose Corporate Summary
7.2.2 Inbiose Business Overview
7.2.3 Inbiose Human Milk Oligosaccharides (HMO) Major Product Offerings
7.2.4 Inbiose Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2017-2022)
7.2.5 Inbiose Key News
7.3 Glycom
7.3.1 Glycom Corporate Summary
7.3.2 Glycom Business Overview
7.3.3 Glycom Human Milk Oligosaccharides (HMO) Major Product Offerings
7.3.4 Glycom Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2017-2022)
7.3.5 Glycom Key News
7.4 Chr. Hansen (Jennewein)
7.4.1 Chr. Hansen (Jennewein) Corporate Summary
7.4.2 Chr. Hansen (Jennewein) Business Overview
7.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Major Product Offerings
7.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2017-2022)
7.4.5 Chr. Hansen (Jennewein) Key News
7.5 ZuChem
7.5.1 ZuChem Corporate Summary
7.5.2 ZuChem Business Overview
7.5.3 ZuChem Human Milk Oligosaccharides (HMO) Major Product Offerings
7.5.4 ZuChem Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2017-2022)
7.5.5 ZuChem Key News
7.6 Glycom
7.6.1 Glycom Corporate Summary
7.6.2 Glycom Business Overview
7.6.3 Glycom Human Milk Oligosaccharides (HMO) Major Product Offerings
7.6.4 Glycom Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2017-2022)
7.6.5 Glycom Key News
8 Global Human Milk Oligosaccharides (HMO) Production Capacity, Analysis
8.1 Global Human Milk Oligosaccharides (HMO) Production Capacity, 2017-2028
8.2 Human Milk Oligosaccharides (HMO) Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Milk Oligosaccharides (HMO) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Milk Oligosaccharides (HMO) Supply Chain Analysis
10.1 Human Milk Oligosaccharides (HMO) Industry Value Chain
10.2 Human Milk Oligosaccharides (HMO) Upstream Market
10.3 Human Milk Oligosaccharides (HMO) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Milk Oligosaccharides (HMO) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Human Milk Oligosaccharides (HMO) in Global Market
Table 2. Top Human Milk Oligosaccharides (HMO) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Milk Oligosaccharides (HMO) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Milk Oligosaccharides (HMO) Revenue Share by Companies, 2017-2022
Table 5. Global Human Milk Oligosaccharides (HMO) Sales by Companies, (Tons), 2017-2022
Table 6. Global Human Milk Oligosaccharides (HMO) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Milk Oligosaccharides (HMO) Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Human Milk Oligosaccharides (HMO) Product Type
Table 9. List of Global Tier 1 Human Milk Oligosaccharides (HMO) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Milk Oligosaccharides (HMO) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Milk Oligosaccharides (HMO) Sales (Tons), 2017-2022
Table 15. By Type - Global Human Milk Oligosaccharides (HMO) Sales (Tons), 2023-2028
Table 16. By Application – Global Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Milk Oligosaccharides (HMO) Sales (Tons), 2017-2022
Table 20. By Application - Global Human Milk Oligosaccharides (HMO) Sales (Tons), 2023-2028
Table 21. By Region – Global Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Milk Oligosaccharides (HMO) Sales (Tons), 2017-2022
Table 25. By Region - Global Human Milk Oligosaccharides (HMO) Sales (Tons), 2023-2028
Table 26. By Country - North America Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Milk Oligosaccharides (HMO) Sales, (Tons), 2017-2022
Table 29. By Country - North America Human Milk Oligosaccharides (HMO) Sales, (Tons), 2023-2028
Table 30. By Country - Europe Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Milk Oligosaccharides (HMO) Sales, (Tons), 2017-2022
Table 33. By Country - Europe Human Milk Oligosaccharides (HMO) Sales, (Tons), 2023-2028
Table 34. By Region - Asia Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Milk Oligosaccharides (HMO) Sales, (Tons), 2017-2022
Table 37. By Region - Asia Human Milk Oligosaccharides (HMO) Sales, (Tons), 2023-2028
Table 38. By Country - South America Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Milk Oligosaccharides (HMO) Sales, (Tons), 2017-2022
Table 41. By Country - South America Human Milk Oligosaccharides (HMO) Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Sales, (Tons), 2023-2028
Table 46. Abbott Corporate Summary
Table 47. Abbott Human Milk Oligosaccharides (HMO) Product Offerings
Table 48. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Inbiose Corporate Summary
Table 50. Inbiose Human Milk Oligosaccharides (HMO) Product Offerings
Table 51. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Glycom Corporate Summary
Table 53. Glycom Human Milk Oligosaccharides (HMO) Product Offerings
Table 54. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Chr. Hansen (Jennewein) Corporate Summary
Table 56. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Offerings
Table 57. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. ZuChem Corporate Summary
Table 59. ZuChem Human Milk Oligosaccharides (HMO) Product Offerings
Table 60. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Glycom Corporate Summary
Table 62. Glycom Human Milk Oligosaccharides (HMO) Product Offerings
Table 63. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Human Milk Oligosaccharides (HMO) Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 65. Global Human Milk Oligosaccharides (HMO) Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Human Milk Oligosaccharides (HMO) Production by Region, 2017-2022 (Tons)
Table 67. Global Human Milk Oligosaccharides (HMO) Production by Region, 2023-2028 (Tons)
Table 68. Human Milk Oligosaccharides (HMO) Market Opportunities & Trends in Global Market
Table 69. Human Milk Oligosaccharides (HMO) Market Drivers in Global Market
Table 70. Human Milk Oligosaccharides (HMO) Market Restraints in Global Market
Table 71. Human Milk Oligosaccharides (HMO) Raw Materials
Table 72. Human Milk Oligosaccharides (HMO) Raw Materials Suppliers in Global Market
Table 73. Typical Human Milk Oligosaccharides (HMO) Downstream
Table 74. Human Milk Oligosaccharides (HMO) Downstream Clients in Global Market
Table 75. Human Milk Oligosaccharides (HMO) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Milk Oligosaccharides (HMO) Segment by Type
Figure 2. Human Milk Oligosaccharides (HMO) Segment by Application
Figure 3. Global Human Milk Oligosaccharides (HMO) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Milk Oligosaccharides (HMO) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Milk Oligosaccharides (HMO) Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Milk Oligosaccharides (HMO) Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Human Milk Oligosaccharides (HMO) Revenue in 2021
Figure 9. By Type - Global Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Milk Oligosaccharides (HMO) Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Milk Oligosaccharides (HMO) Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 19. US Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 24. Germany Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 33. China Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 40. Brazil Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Market Share, 2017-2028
Figure 44. Turkey Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Milk Oligosaccharides (HMO) Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Human Milk Oligosaccharides (HMO) by Region, 2021 VS 2028
Figure 50. Human Milk Oligosaccharides (HMO) Industry Value Chain
Figure 51. Marketing Channels
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|